Varian Associates of Palo Alto, CA, has sold the most powerfulwhole-body MRI scanner ever to be acquired by a Japanese laboratory. A Varian 4-tesla scanner will be installed this month at theInstitute of Physical and Chemical Research (RIKEN) in Wako
Varian Associates of Palo Alto, CA, has sold the most powerfulwhole-body MRI scanner ever to be acquired by a Japanese laboratory.
A Varian 4-tesla scanner will be installed this month at theInstitute of Physical and Chemical Research (RIKEN) in Wako City,Japan. It will be operated under the direction of Dr. Keiji Tanaka,head of RIKEN's neural information processing laboratory, to studybrain functions, such as recognition, memory, and motor programming.
The $4 million system consists of Varian's Unity Inova spectrometerand a magnet and gradient coils supplied by Siemens Medical Systems.It is the second 4-tesla scanner built by Varian since the companyreentered the ultra-high-field MRI manufacturing sector in 1995(SCAN 3/27/96). The other system was installed in Canada in Marchat Robarts Research Institute in London, Ontario.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
The Reading Room Podcast: A Closer Look at Remote MRI Safety, Part 2
July 25th 2025In the second of a multi-part podcast episode, Emanuel Kanal, M.D. and Tobias Gilk, MRSO, MRSE, share their perspectives on remote MRI safety protocols for ensuring screening accuracy and adherence to conditional implant guidelines as well as a rapid and effective response to adverse events.
The Reading Room Podcast: Current and Emerging Insights on Abbreviated Breast MRI, Part 2
July 23rd 2025In the second part of a multi-part podcast episode, Stamatia Destounis, MD, Emily Conant, MD and Habib Rahbar, MD, discuss key sequences for abbreviated breast MRI and how it stacks up to other breast cancer screening modalities.
Chest CT for Post-COVID-19 Abnormalities: Nine Takeaways from a Multi-Society Consensus Statement
July 22nd 2025Developed by 21 thoracic radiologists, the new international consensus statement addresses appropriate indications, scan acquisition and keys to reporting for the use of chest CT imaging in evaluating for residual lung abnormalities from COVID-19.